Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first once-daily fixed-dose combination therapy to treat hep C has hit the scene, with neither interferon nor ribavirin in tow.
I am outraged that Gilead refuses to study 7977 with other DAAs that are farther along than their own drugs.
The Fair Pricing Coalition and other activists are taking Gilead Sciences to task for what they say is an exorbitant per-patient annual wholes...
The AIDS Treatment Activists Coalition is asking people to sign on to a letter in support of a proposed U.S. Food and Drug Administration...
Some of the bravest, most dogged and downright effective AIDS fighters we know
In the past month, two companies shelved their once-promising experimental HIV drugs, citing the challenging nature of bringing a...
Abbott is gearing up to release its long-awaited Norvir (ritonavir) tablet. The company states that it will negotiate the price—which has...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.